FRACTYL HEALTH/$GUTS
1D1W1MYTD1Y5YMAX
Capital at risk
About FRACTYL HEALTH
Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.
- Ticker
- $GUTS
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 100
- Headquarters
- Burlington, United States
- Website
- fractyl.com
FRACTYL HEALTH Metrics
BasicAdvanced
$87M
-
-$0.81
2.32
-
Price and volume
Market cap
$87M
Beta
2.32
52-week high
$2.45
52-week low
$0.38
Average daily volume
1.7M
Financial strength
Current ratio
3.152
Quick ratio
2.996
Long term debt to equity
-33.367
Total debt to equity
-36.478
Profitability
EBITDA (TTM)
-84.766
Management effectiveness
Return on assets (TTM)
-74.57%
Return on equity (TTM)
1,063.04%
Valuation
Price to book
-51.88
Price to tangible book (TTM)
-51.88
Price to free cash flow (TTM)
-0.863
Free cash flow yield (TTM)
-115.92%
Free cash flow per share (TTM)
-0.631
Growth
Earnings per share change (TTM)
-60.59%
3-year earnings per share growth (CAGR)
-72.64%
What the Analysts think about FRACTYL HEALTH
Analyst ratings (Buy, Hold, Sell) for FRACTYL HEALTH stock.
Analyst projections of the future price of FRACTYL HEALTH stock.
FRACTYL HEALTH Financial Performance
Revenues and expenses
FRACTYL HEALTH Earnings Performance
Company profitability
Upcoming events
No upcoming events
FRACTYL HEALTH News
AllArticlesVideos
GUTS CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Fractyl Investors of Securities Class Action Lawsuit Deadline on October 20, 2026
Newsfile Corp23 hours ago
Robbins LLP is Investigating Allegations that Fractyl Health, Inc. Misled Investors Regarding the Viability and Efficacy of its Revita DMR System
Newsfile Corp2 days ago
GUTS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Fractyl Investors of Securities Class Action Lawsuit Deadline on October 20, 2026
Newsfile Corp3 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.